- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Severe Hypoglycemia may Increase Risk of QTc Prolongation in diabetes patients
Previous studies have shown that severe hypoglycemia (SH) has been linked to increased cardiovascular and all-cause mortality among people with T2D and also to QTc prolongation. A recent study reiterated the association between SH and corrected QT (QTc) interval prolongation in type 2 diabetes (T2DM). The study findings were published in The Journal of Clinical Endocrinology & Metabolism on April 09, 2022.
Several studies have demonstrated that insulin-induced hypoglycemia in diabetes causes the prolongation of corrected QT (QTc) interval, which is associated with ventricular arrhythmias and sudden death. However, only a few large studies have addressed SH and QTc intervals in people with T2D. Therefore, Dr Justin B Echouffo-Tcheugui and his team conducted a study to evaluate the association of SH with QTc prolongation in adults with T2DM.
In this prospective analysis, the researchers assessed data of 8277 participants without baseline QTc prolongation from the Action to Control Cardiovascular Risk in Diabetes Study. They evaluated SH over a 24-month period. They monitored incident QTc prolongation using follow-up electrocardiograms. They used modified Poisson regression to generate risk ratios (RR) and 95% confidence intervals (CI) for QTc prolongation.
Key findings of the study:
- Over a median of 5 years, the researchers observed that 517 individuals developed QTc prolongation (6.3%).
- They found that the participants with SH had a 66% higher risk of QTc prolongation (RR 1.66).
- They also found that the incidence of QTc prolongation was 10.3% (27/261) and 14.3% (9/63) for participants with 1 and ≥2 SH, respectively.
- Compared to no SH, they noted that the RRs for patients with 1 and ≥2 SH were 1.57 and 2.01, respectively.
- They noted that age modified the association of SH with QTc prolongation (PInteraction=0.008).
- They reported that the association remained significant among younger participants (<61.9years [median age]: RR 2.63), but was nonsignificant among older participants (≥61.9years: RR 1.37).
The authors concluded, "In a large population with T2DM, SH was associated with an increased risk of QTc prolongation independently of other risk factors such as cardiac autonomic neuropathy. The association was strongest among younger participants".
For further information:
DOI: https://doi.org/10.1210/clinem/dgac195
Keywords: hypoglycaemia, QT interval, type 2 diabetes, epidemiology, electrocardiography, QTc Prolongation, severe hypoglycemia, Journal of Clinical Endocrinology & Metabolism.
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751